Denise Pierce has moderated and help plan many of FLASCO’s conferences. She is a huge asset to FLASCO in countless ways. Congratulations Denise you deserve it!! DK Pierce chosen as one of 2015 Indiana Companies to Watch 2015 has been quite a milestone year for DK Pierce & Associates (DK Pierce), and I wanted…
FLASCO Member, Dr. Napoleon Santos joins Florida Cancer Specialists Florida Cancer Specialists & Research Institute and FLASCO are pleased to announce that Napoleon Santos, DO, has joined Florida Cancer Specialists and will be seeing patients at the FCS cancer center in West Palm Beach, located at 1309 N. Flagler Drive, West Palm Beach, FL 33401….
Sonidegib (Odomzo Capsules) Approved by FDA (Novartis Pharmaceuticals Corporation) FDA approved sonidegib (Odomzo Capsules, Novartis Pharmaceuticals Corporation) for the treatment of patients with locally advanced basal cell carcinoma (BCC) that has recurred following surgery or radiation therapy, or those who are not candidates for surgery or radiation therapy. July 24, 2015. More Information: http://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm455865.htm
Carfilzomib (Kyprolis) Approved by FDA (Onyx Pharmaceuticals, Inc., an Amgen Subsidiary) On July 24, 2015, the U.S. Food and Drug Administration approved a new indication for Kyprolis® (carfilzomib) for injection.1 KYPROLIS can now be used in combination with lenalidomide and dexamethasone for the treatment of patients with relapsed multiple myeloma who have received one to…
UnitedHealthcare discovered a programming error in their claims system that has been incorrectly denying prior authorized chemotherapy treatments. This notice was placed on the company’s portal on July 23, 2015. HCFA Physician Chemotherapy Claims Processing Errors and Recovery UnitedHealthcare launched its Injectable Outpatient Chemotherapy Prior Authorization program requirement effective June 1, 2015 to improve the…
Afatinib versus Erlotinib as Second-line Treatment Phase III Clinical Trial Update Boehringer Ingelheim Pharmaceuticals, Inc. would like to share the overall survival (OS) data from a head-to-head Phase III clinical trial that was recently published in The Lancet Oncology. The study evaluated the company’s lung cancer treatment as a potential option for patients with advanced…
YOU’RE INVITED TO MAKE A DIFFERENCE! Join the Florida Academy of Physician Assistants for our Capitol Hill Days this November 2-4, 2015, at the Four Points by Sheraton in Tallahassee, Florida! Because the 2016 Legislative Session will begin two months earlier than usual, FAPA has scheduled Capitol Hill Days earlier, too. Register by September 1,…
Florida Cancer Affiliates to Host Stress Reduction Support Group Meetings Trinity, Florida (July 22, 2015) — Florida Cancer Affiliates (FCA), a community-based medical oncology, hematology and radiation oncology practice, announces that its new Trinity center will host a stress reduction support group meeting once a month on a Wednesday from 6 pm to 7:30 pm…
In a Pivotal Study, Genentech’s Investigational Immunotherapy Atezolizumab Shrank Tumors in People With a Specific Type of Bladder Cancer Results showed that high levels of PD-L1 expression were associated with greater responses to atezolizumab Genentech will discuss results with the U.S. Food and Drug Administration (FDA) as part of atezolizumab’s Breakthrough Therapy Designation in bladder…
Genentech CoPay Program Update Effective June 30th the Genentech CoPay Program made the following changes: Genentech has a co-pay card program for eligible patients with private insurance taking Genentech cancer medicines. The co-pay program helps to cover eligible patients’ monthly costs so patients pay $25 co-pay per medicine. The card covers up to $25,000 per…
The importance of nurses in cancer care The Lancet Oncology Volume 16, No. 7, p737, July 2015 In early June, 2015, it became apparent that the UK National Health Service (NHS) had spent £3·3 billion on temporary nurses’ agency fees in the past financial year. Health Secretary Jeremy Hunt ascribed this increased use of agency…
AstraZeneca recently received approval from the Food and Drug Administration for IRESSA® (gefitinib) as a first-line treatment in patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test. IRESSA is approved in 91 countries…
The Oncofertility Consortium® is a national, interdisciplinary initiative designed to explore the reproductive future of cancer survivors. Survival rates among young cancer patients have steadily increased over the past four decades in part because of the development of more effective cancer treatments. Today, both women and men can look forward to life after cancer, yet…
Since 1997, the LIVESTRONG Society has been working to improve the lives of people affected by cancer. They started as a small group trying to raise money to fight the disease. As cancer has quietly become the world’s leading cause of death, their work has expanded and now reaches every corner of the globe. One…
This educational resource is provided by Celgene and designed to provide an understanding of the classification, diagnosis of subtypes, and disease management of peripheral T-cell lymphoma (PTCL) and cutaneous T-cell lymphoma (CTCL). Physicians can choose to “follow” the resource center and receive alerts when new information is added. To visit the T-cell Lymphoma Resource Center,…
The Florida Breast Cancer Foundation would like to share the following good news!! In case you haven’t heard the good news, we are thrilled to announce that last night, we were not only able to restore the current year funding of $1.8 million, but also INCREASED it, bringing funding for the program to an all-time…
Mohammad Jahanzeb, M.D., Medical Director of Sylvester Comprehensive Cancer Center at Deerfield Beach, has been appointed Chair-Elect of the American Society of Clinical Oncology’s Quality Oncology Practice Initiative (QOPI®) Steering Group Committee. Jahanzeb, professor of medicine, has been instrumental in the development of QOPI since its inception in 2002. He has served as a member…
April 10th and 11th FLASCO held its Annual Meeting and Spring Session in Orlando at the Marriott World Center. We would like to express a special thanks to the FLASCO Program Committee for all of their hard work in planning the Spring General Session. There were great speakers with informative and captivating presentations. Thank you to…
A special thanks is extended to Dr. Thomas Marsland for all of his efforts in planning and implementing a very successful Business of Oncology Conference on April 10th. We had 240 attendees at this great conference. Thanks to all who attended and participated in this event. Additionally, a special thanks is extended to Denise Pierce,…
VeriStrat® Lung Cancer Journal: VeriStrat Proteomic Test Improves Overall Survival and Decreases Medical Costs for Patients with Advanced NSCLC BOULDER, Colo.—March 24, 2015— Biodesix, Inc. today announced the publication in the journal Lung Cancer of a pivotal paper demonstrating the economic implications to the US healthcare system of using VeriStrat® in guiding treatment of…
Mayo Clinic Hem/Onc Reviews 2015 Mayo Clinic would like to invite Fellows to submit a research abstract for the 16th Annual Mayo Clinic Hematology/Oncology Fellows’ Research Symposium as part of the 25th Annual Mayo Clinic Hematology/Oncology Reviews scheduled for July 29 – August 1, 2015 at The Ritz Carlton in Amelia Island, FL. Fellows are invited to submit…
The Goal of the FLASCO Foundation, Inc., Outreach program is to bring together cancer patients, cancer survivors, caregivers, oncology experts and corporate supporters together to learn and exchange information on various types of cancer. This project was the dream of Past President Gerald Robbins, MD. This was one of his main initiatives and it was…
Friday, April 10 join us at the Marriott Orlando World Center to learn the art of navigating the increasingly complex map of clinical practice. Hear how each of the stakeholders are approaching the current terrain and what they are doing to prepare for the next big curve in the road. Plan to stay to hear…
Florida Cancer Specialists & Research Institute Announces New Office Location in Hudson, FL Nation’s Largest Independent Oncology/Hematology Practice Relocating Office in Pasco County Hudson, FL – January 15, 2015 . . . . Florida Cancer Specialists & Research Institute (FCS), the largest independent medical oncology/hematology practice in the United States, announced a new clinical location in Hudson,…
Campaign to Educate Young Women About Breast Cancer Risks Reauthorized by House WASHINGTON – The Breast Health Education and Awareness Requires Learning Young Act, or the EARLY Act, was reauthorized for five years today by the House of Representatives. H.R. 5185 was introduced by Rep. Debbie Wasserman Schultz (D-Fla.) and Rep. Renee Ellmers (R-N.C.). Authored…
The Foundation of Collier County Medical Society has introduced a new scholarship award for medical students who are Florida residents and have demonstrated excellence in community service. April Donahue, Executive Director of Collier County Medical Society, would be very grateful if you could forward this information to medical students that you come into contact with. The…
Support for Partnerships to Promote Healthy Living The BUILD Health Challenge is a national program designed to support community collaborations that are working to give everyone a fair chance to be healthy. Specifically, the Challenge provides awards to strengthen partnerships among hospitals, nonprofit organizations, local health departments, and other community organizations to improve the health of…
Dr. Wasif Riaz Joins Florida Cancer Specialists & Research Institute Nation’s Largest Independent Hematology/Oncology Practice Welcomes New Physician to Sebring Office Fort Myers, FL – December 3, 2014 . . . . Florida Cancer Specialists & Research Institute (FCS), the largest independent medical oncology/hematology practice in the United States, is pleased to announce that Wasif Riaz, MD,…
CMS releases new proposal to improve Accountable Care Organizations Shared Savings Program Proposed Rule reflects focus on primary care and improved incentives for participation, quality, and efficiency The Centers for Medicare & Medicaid Services (CMS) today released a proposal to strengthen the Shared Savings Program for Accountable Care Organizations (ACOs) through a greater emphasis on…
Drs. Karin Bigman, Eric Harris and Mudussara Khan Join Florida Cancer Specialists & Research Institute Nation’s Largest Independent Oncology/Hematology Practice Adds New Offices in Daytona and Ormond Beach Fort Myers, FL – December 4, 2014 . . . . Florida Cancer Specialists & Research Institute (FCS), the leading community oncology/hematology practice in Florida, is pleased…
The link below will take you to the FMA website. Facing a medical audit? Use this toolkit as your guide The Physicians Advocacy Institute (PAI) and the American College of Emergency Physicians (ACEP) have published a Toolkit for Physicians Facing Medical Audits. The FMA has partnered with PAI and ACEP to disseminate this toolkit, which…
Clicking below will take you to the FMA website who will share the latest on the Affordable Care Act. Update on the Affordable Care Act Click here for the latest Affordable Care Act update from FMA Director of Payment Advocacy Jarrod Fowler, including an analysis of a recent Government Accountability Office report on competition and…
Florida Cancer Specialists & Research Institute Announces $2.5 Million Expansion of Corporate Headquarters Nation’s Largest Independent Oncology/Hematology Practice Holds Groundbreaking Ceremony to Accommodate Growth Fort Myers, FL – December 4, 2014 . . . . Florida Cancer Specialists & Research Institute (FCS), the largest independent medical oncology/hematology practice in the United States, announced a $2.5 million expansion…
© 2021 FLASCO | Premium Website Design by The HDG
